Neoadjuvant treatment with trastuzumab and folfox induces a complete pathologic response in a metastatic ERBB2 (HER2)-Amplified Duodenal Cancer

Ahmad Hamad, Aatur D. Singhi, Nathan Bahary, Kevin McGrath, Rula Amarin, Herbert J. Zeh, Amer H. Zureikat

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant treatment with trastuzumab and folfox induces a complete pathologic response in a metastatic ERBB2 (HER2)-Amplified Duodenal Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences